4//SEC Filing
Haasner Dirk 4
Accession 0001209191-20-064649
CIK 0001636651other
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 4:38 PM ET
Size
5.5 KB
Accession
0001209191-20-064649
Insider Transaction Report
Form 4
Haasner Dirk
SVP, Global Regulatory Affairs
Transactions
- Award
Stock Option (Right to Buy)
2020-12-17+100,000→ 100,000 totalExercise: $2.82Exp: 2030-12-16→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on December 17, 2021 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.
Documents
Issuer
Ovid Therapeutics Inc.
CIK 0001636651
Entity typeother
Related Parties
1- filerCIK 0001704660
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 4:38 PM ET
- Size
- 5.5 KB